ACHC Quote, Financials, Valuation and Earnings

HCA Healthcare, Inc. has a net margin of 4.5% compared to Acadia Healthcare Co., Inc.'s net margin of 9.93%. Acadia Healthcare Co., Inc.'s return on equity of 3.71% beat HCA Healthcare, Inc.'s return on equity of 3428.29%.

Acadia Healthcare Co., Inc. has a consensus price target of $21.57, signalling upside risk potential of 47.35%. On the other hand HCA Healthcare, Inc. has an analysts' consensus of $477.70 which suggests that it could fall by -2.04%. Given that Acadia Healthcare Co., Inc. has higher upside potential than HCA Healthcare, Inc., analysts believe Acadia Healthcare Co., Inc. is more attractive than HCA Healthcare, Inc..

Acadia Healthcare Co., Inc. has a beta of 0.906, which suggesting that the stock is 9.448% less volatile than S&P 500. In comparison HCA Healthcare, Inc. has a beta of 1.361, suggesting its more volatile than the S&P 500 by 36.09%.

Acadia Healthcare Co., Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. HCA Healthcare, Inc. offers a yield of 0.58% to investors and pays a quarterly dividend of $0.72 per share. Acadia Healthcare Co., Inc. pays -- of its earnings as a dividend. HCA Healthcare, Inc. pays out 12% of its earnings as a dividend. HCA Healthcare, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Acadia Healthcare Co., Inc. quarterly revenues are $851.6M, which are smaller than HCA Healthcare, Inc. quarterly revenues of $19.2B. Acadia Healthcare Co., Inc.'s net income of $38.3M is lower than HCA Healthcare, Inc.'s net income of $1.9B. Notably, Acadia Healthcare Co., Inc.'s price-to-earnings ratio is 12.42x while HCA Healthcare, Inc.'s PE ratio is 18.85x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Acadia Healthcare Co., Inc. is 0.41x versus 1.61x for HCA Healthcare, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Nutex Health, Inc. has a net margin of 4.5% compared to Acadia Healthcare Co., Inc.'s net margin of 36.15%. Acadia Healthcare Co., Inc.'s return on equity of 3.71% beat Nutex Health, Inc.'s return on equity of 97.36%.

Acadia Healthcare Co., Inc. has a consensus price target of $21.57, signalling upside risk potential of 47.35%. On the other hand Nutex Health, Inc. has an analysts' consensus of $250.00 which suggests that it could grow by 89.75%. Given that Nutex Health, Inc. has higher upside potential than Acadia Healthcare Co., Inc., analysts believe Nutex Health, Inc. is more attractive than Acadia Healthcare Co., Inc..

Acadia Healthcare Co., Inc. has a beta of 0.906, which suggesting that the stock is 9.448% less volatile than S&P 500. In comparison Nutex Health, Inc. has a beta of -0.034, suggesting its less volatile than the S&P 500 by 103.384%.

Acadia Healthcare Co., Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutex Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Acadia Healthcare Co., Inc. pays -- of its earnings as a dividend. Nutex Health, Inc. pays out -- of its earnings as a dividend.

Acadia Healthcare Co., Inc. quarterly revenues are $851.6M, which are larger than Nutex Health, Inc. quarterly revenues of $267.8M. Acadia Healthcare Co., Inc.'s net income of $38.3M is lower than Nutex Health, Inc.'s net income of $96.8M. Notably, Acadia Healthcare Co., Inc.'s price-to-earnings ratio is 12.42x while Nutex Health, Inc.'s PE ratio is 7.10x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Acadia Healthcare Co., Inc. is 0.41x versus 0.82x for Nutex Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Tenet Healthcare Corp. has a net margin of 4.5% compared to Acadia Healthcare Co., Inc.'s net margin of 10.95%. Acadia Healthcare Co., Inc.'s return on equity of 3.71% beat Tenet Healthcare Corp.'s return on equity of 27.14%.

Acadia Healthcare Co., Inc. has a consensus price target of $21.57, signalling upside risk potential of 47.35%. On the other hand Tenet Healthcare Corp. has an analysts' consensus of $234.33 which suggests that it could grow by 10.88%. Given that Acadia Healthcare Co., Inc. has higher upside potential than Tenet Healthcare Corp., analysts believe Acadia Healthcare Co., Inc. is more attractive than Tenet Healthcare Corp..

Acadia Healthcare Co., Inc. has a beta of 0.906, which suggesting that the stock is 9.448% less volatile than S&P 500. In comparison Tenet Healthcare Corp. has a beta of 1.444, suggesting its more volatile than the S&P 500 by 44.378%.

Acadia Healthcare Co., Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tenet Healthcare Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Acadia Healthcare Co., Inc. pays -- of its earnings as a dividend. Tenet Healthcare Corp. pays out -- of its earnings as a dividend.

Acadia Healthcare Co., Inc. quarterly revenues are $851.6M, which are smaller than Tenet Healthcare Corp. quarterly revenues of $5.3B. Acadia Healthcare Co., Inc.'s net income of $38.3M is lower than Tenet Healthcare Corp.'s net income of $579M. Notably, Acadia Healthcare Co., Inc.'s price-to-earnings ratio is 12.42x while Tenet Healthcare Corp.'s PE ratio is 14.49x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Acadia Healthcare Co., Inc. is 0.41x versus 0.94x for Tenet Healthcare Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Universal Health Services, Inc. has a net margin of 4.5% compared to Acadia Healthcare Co., Inc.'s net margin of 8.43%. Acadia Healthcare Co., Inc.'s return on equity of 3.71% beat Universal Health Services, Inc.'s return on equity of 20.13%.

Acadia Healthcare Co., Inc. has a consensus price target of $21.57, signalling upside risk potential of 47.35%. On the other hand Universal Health Services, Inc. has an analysts' consensus of $249.94 which suggests that it could grow by 8.6%. Given that Acadia Healthcare Co., Inc. has higher upside potential than Universal Health Services, Inc., analysts believe Acadia Healthcare Co., Inc. is more attractive than Universal Health Services, Inc..

Acadia Healthcare Co., Inc. has a beta of 0.906, which suggesting that the stock is 9.448% less volatile than S&P 500. In comparison Universal Health Services, Inc. has a beta of 1.272, suggesting its more volatile than the S&P 500 by 27.185%.

Acadia Healthcare Co., Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Universal Health Services, Inc. offers a yield of 0.35% to investors and pays a quarterly dividend of $0.20 per share. Acadia Healthcare Co., Inc. pays -- of its earnings as a dividend. Universal Health Services, Inc. pays out 4.76% of its earnings as a dividend. Universal Health Services, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Acadia Healthcare Co., Inc. quarterly revenues are $851.6M, which are smaller than Universal Health Services, Inc. quarterly revenues of $4.5B. Acadia Healthcare Co., Inc.'s net income of $38.3M is lower than Universal Health Services, Inc.'s net income of $379.1M. Notably, Acadia Healthcare Co., Inc.'s price-to-earnings ratio is 12.42x while Universal Health Services, Inc.'s PE ratio is 10.94x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Acadia Healthcare Co., Inc. is 0.41x versus 0.89x for Universal Health Services, Inc.. Usually stocks with elevated PS ratios are considered overvalued.